Back to search

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.

Data up to Jan 2025

Published1997
Citations211
References27

Total Citations Per Year

Abstract

References (27)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis

1996 • 1,885 citations

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.

1996 • 907 citations

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

1995 • 766 citations

Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia

1991 • 723 citations

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

1995 • 566 citations

Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia

1989 • 457 citations

High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia

1995 • 454 citations

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1991 • 387 citations

The t(12;21) Translocation Converts AML-1B from an Activator to a Repressor of Transcription

1996 • 284 citations

Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation

1981 • 264 citations

Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.

1992 • 248 citations

Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting age

1996 • 241 citations

Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study

1990 • 228 citations

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia.

1994 • 212 citations

Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia.

1994 • 203 citations

A direct bone marrow chromosome technique for acute lymphoblastic leukemia

1984 • 193 citations

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.

1996 • 185 citations

Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study

1994 • 183 citations

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia

1995 • 173 citations

Biology and treatment of acute lymphoblastic leukemia

1994 • 140 citations

Different molecular consequences of the 1;19 chromosomal translocation in childhood B-cell precursor acute lymphoblastic leukemia

1992 • 127 citations

Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome.

1996 • 126 citations

Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features [see comments]

1992 • 85 citations

Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia

1989 • 67 citations

High incidence of tel/amli fusion resulting from a cryptic t( 12;21 ) in childhood b-lineage acute lymphoblastic leukemia in Taiwan

1996 • 4 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with… (1997) – Journal of Clinical Oncology | Metascience Observatory Explorer